Table 5 Concordance rates and agreement between manual and AI-assisted HER2 scoring
Manual A | Manual B | HER2-Non-amplified | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Manual A | Manual B | ||||||||||||||
HER2 0 | HER2 1+ | HER2 2+ | HER2 3+ | CR | κ | P | HER2 0 | HER2 1+ | HER2 2+ | HER2 3+ | CR | κ | P | ||
HER2 0 | 68 | 14 | 0 | 0 | 79.43% | 0.711 | <0.001 | HER2 0 | 68 | 14 | 0 | 0 | 77.02% | 0.61 | <0.001 |
HER2 1+ | 10 | 45 | 2 | 0 | HER2 1+ | 10 | 45 | 1 | 0 | ||||||
HER2 2+ | 0 | 12 | 21 | 0 | HER2 2+ | 0 | 12 | 11 | 0 | ||||||
HER2 3+ | 0 | 0 | 5 | 32 | HER2 3+ | 0 | 0 | 0 | 0 | ||||||
AI-a A | AI-a B | AI-a A | AI-a B | ||||||||||||
HER2 0 | HER2 1+ | HER2 2+ | HER2 3+ | CR | κ | P | HER2 0 | HER2 1+ | HER2 2+ | HER2 3+ | CR | κ | P | ||
HER2 0 | 62 | 2 | 0 | 0 | 85.17% | 0.794 | <0.001 | HER2 0 | 62 | 2 | 0 | 0 | 82.61% | 0.713 | <0.001 |
HER2 1+ | 17 | 55 | 2 | 0 | HER2 1+ | 17 | 55 | 2 | 0 | ||||||
HER2 2+ | 0 | 8 | 23 | 1 | HER2 2+ | 0 | 7 | 16 | 0 | ||||||
HER2 3+ | 0 | 0 | 1 | 38 | HER2 3+ | 0 | 0 | 0 | 0 | ||||||
Manual CS | Manual A | HER2-Non-amplified | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Manual CS | Manual A | ||||||||||||||
HER2 0 | HER2 1+ | HER2 2+ | HER2 3+ | CR | κ | P | HER2 0 | HER2 1+ | HER2 2+ | HER2 3+ | CR | κ | P | ||
HER2 0 | 70 | 5 | 0 | 0 | 86.60% | 0.813 | <0.001 | HER2 0 | 70 | 5 | 0 | 0 | 85.09% | 0.751 | <0.001 |
HER2 1+ | 12 | 50 | 6 | 0 | HER2 1+ | 12 | 50 | 6 | 0 | ||||||
HER2 2+ | 0 | 2 | 27 | 3 | HER2 2+ | 0 | 1 | 17 | 0 | ||||||
HER2 3+ | 0 | 0 | 0 | 34 | HER2 3+ | 0 | 0 | 0 | 0 | ||||||
AI-a CS | AI-a A | AI-a CS | AI-a A | ||||||||||||
HER2 0 | HER2 1+ | HER2 2+ | HER2 3+ | CR | κ | P | HER2 0 | HER2 1+ | HER2 2+ | HER2 3+ | CR | κ | P | ||
HER2 0 | 62 | 7 | 0 | 0 | 91.39% | 0.881 | <0.001 | HER2 0 | 62 | 7 | 0 | 0 | 90.06% | 0.836 | <0.001 |
HER2 1+ | 2 | 65 | 5 | 0 | HER2 1+ | 2 | 65 | 5 | 0 | ||||||
HER2 2+ | 0 | 2 | 26 | 1 | HER2 2+ | 0 | 2 | 18 | 0 | ||||||
HER2 3+ | 0 | 0 | 1 | 38 | HER2 3+ | 0 | 0 | 0 | 0 | ||||||
Manual CS | Manual B | HER2-Non-amplified | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Manual CS | Manual B | ||||||||||||||
HER2 0 | HER2 1+ | HER2 2+ | HER2 3+ | CR | κ | P | HER2 0 | HER2 1+ | HER2 2+ | HER2 3+ | CR | κ | P | ||
HER2 0 | 73 | 2 | 0 | 0 | 92.82% | 0.899 | <0.001 | HER2 0 | 73 | 2 | 0 | 0 | 91.93% | 0.861 | <0.001 |
HER2 1+ | 5 | 63 | 0 | 0 | HER2 1+ | 5 | 63 | 0 | 0 | ||||||
HER2 2+ | 0 | 6 | 26 | 0 | HER2 2+ | 0 | 6 | 12 | 0 | ||||||
HER2 3+ | 0 | 0 | 2 | 32 | HER2 3+ | 0 | 0 | 0 | 0 | ||||||
AI-a CS | AI-a B | AI-a CS | AI-a B | ||||||||||||
HER2 0 | HER2 1+ | HER2 2+ | HER2 3+ | CR | κ | P | HER2 0 | HER2 1+ | HER2 2+ | HER2 3+ | CR | κ | P | ||
HER2 0 | 69 | 0 | 0 | 0 | 93.78% | 0.913 | <0.001 | HER2 0 | 69 | 0 | 0 | 0 | 92.55% | 0.875 | <0.001 |
HER2 1+ | 10 | 62 | 0 | 0 | HER2 1+ | 10 | 62 | 0 | 0 | ||||||
HER2 2+ | 0 | 3 | 26 | 0 | HER2 2+ | 0 | 2 | 18 | 0 | ||||||
HER2 3+ | 0 | 0 | 0 | 39 | HER2 3+ | 0 | 0 | 0 | 0 | ||||||